SCHEMBL468311

SCHEMBL468311

CC(C)(C)OC(=O)NCC(c1ccc([N+](=O)[O-])cc1)c1nc(-c2ccccc2)cs1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPRB P23467 2/20 0.48
MAPT P10636 7/20 0.44
ALDH1A1 P00352 5/20 0.44
RAB9A P51151 3/20 0.43
MEN1 O00255 5/20 0.42
KMT2A Q03164 5/20 0.42
LMNA P02545 2/20 0.42
POLB P06746 1/20 0.42
HTT P42858 3/20 0.40
NPC1 O15118 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
CYP1A2 P05177 2/20 0.40
CYP3A4 P08684 2/20 0.40
CYP2C9 P11712 2/20 0.40
CYP2C19 P33261 2/20 0.40
ALOX12 P18054 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
BAZ1A Q9NRL2 1/20 0.39
PPARG P37231 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL679411 0.81 PTPRB (0.71) PTPRB
SCHEMBL679410 0.81 PTPRB (0.71) PTPRB
SCHEMBL17066114 0.77 PTPRB (0.62) PTPRB
SCHEMBL27600689 0.77 KMT2A (0.43) MAPTALDH1A1RAB9AMEN1KMT2A
SCHEMBL468116 0.77 MAPT (0.51) MAPTALDH1A1RAB9AMEN1KMT2A
SCHEMBL21812694 0.76 ALDH1A1 (0.57) MAPTALDH1A1RAB9AMEN1KMT2A
SCHEMBL27600711 0.76 PPARG (0.40) ALDH1A1MEN1KMT2APOLBHTT
SCHEMBL23728158 0.73 NPC1 (0.67) MAPTALDH1A1MEN1KMT2ALMNA
SCHEMBL31234426 0.73 NPC1 (0.67) MAPTALDH1A1MEN1KMT2ALMNA
SCHEMBL27668003 0.73 NPC1 (0.67) MAPTALDH1A1MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2385763-A1 METHODS FOR TREATING VASCULAR LEAK SYNDROME Akebia Therapeutics Inc. (US) 2011-11-16 EP disclosed
US-20110253725-A1 MULTI-PORT BEVERAGE AND FOOD CONTAINERS KILLIAN WILLIAM 2011-10-20 US disclosed
WO-2011005330-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR PREVENTING METASTASIS OF CANCER CELLS AKEBIA THERAPEUTICS INC. (US) 2011-01-13 WO disclosed